
Novo Nordisk just announced that the FDA has cleared its NovoPen Echo insulin injection device, the only one available in the U.S. that’s able to deliver half-unit doses of insulin.
Read more
Novo Nordisk just announced that the FDA has cleared its NovoPen Echo insulin injection device, the only one available in the U.S. that’s able to deliver half-unit doses of insulin.
Read more